RAB11FIP5

Across TCGA pan-cancer cohorts, RAB11FIP5 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RAB11FIP5 data layer compared with 22 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher RAB11FIP5 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RAB11FIP5 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

LSCC, CCRCC, and OV are the cancer types where RAB11FIP5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Median	II,III,IV	0.627	0.908	.001	76	view →
CCRCC	OS	Tertile	II,III,IV	0.972	0.194	.011	12	view →
OV	DFS	Median	All	0.644	1.000	.041	4	view →
LUAD	OS	Quartile	III,IV	0.441	0.957	.031	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RAB11FIP5–LSCC (OS)

Open the LSCC breakdown →